Literature DB >> 29521003

Daily sodium intake influences the relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and hypertension in older adults.

Ivna V Freire1,2,3, Cezar A Casotti1, Ícaro J S Ribeiro1,2, Jonas R D Silva2, Ana A L Barbosa3, Rafael Pereira1,2,3.   

Abstract

The angiotensin-converting enzyme insertion/deletion (I/D) gene polymorphism has been widely reported as being associated with hypertension; however, most studies do not consider environmental/behavioral factors. This study aimed to investigate the relationship among angiotensin-converting enzyme insertion/deletion gene polymorphism, environmental/behavioral factors, and hypertension in community-dwelling elderly individuals. All community-dwelling older adults from Aiquara, Bahia, Brazil, were invited to take part in this study. After exclusions, 234 elderly participants were submitted to a data collection, which included sociodemographics, lifestyle and health status questionnaires, clinical assessment, and blood withdrawal. From the blood samples, the gene polymorphism was identified through polymerase chain reaction and patients grouped as II or D allele carriers (ID and DD genotypes). Hypertension was defined by self-report of the condition and confirmed by antihypertensive drug treatment. Chi-square test was used to identify differences in the proportions distributed between groups of each dependent variable (ie, genotype, diagnosis of hypertension, and blood pressure state from medicated patients with hypertension). The prevalence of hypertension was 59.3% and was associated with diabetes mellitus and obesity, but not with angiotensin-converting enzyme insertion/deletion gene polymorphism. However, carriers of the II genotype, a salt-sensitivity genotype, exhibited a significantly greater estimated sodium intake. In addition, among medicated elderly patients with hypertension, II genotype carriers exhibited poor blood pressure control, despite similar antihypertensive drug treatment in D allele carriers, while exhibiting a greater estimated sodium intake. Our results provide new evidence regarding the interaction of genetic and environmental/behavioral factors in the genesis of hypertension among elderly patients, as well as in blood pressure control in medicated elderly patients with hypertension. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  dietary sodium; genetic polymorphism; hypertension; sodium sensitivity

Mesh:

Substances:

Year:  2018        PMID: 29521003      PMCID: PMC8031090          DOI: 10.1111/jch.13224

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  43 in total

1.  Hardy, Weinberg and language impediments.

Authors:  J F Crow
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

Review 2.  High-salt diet and hypertension: focus on the renin-angiotensin system.

Authors:  I Drenjančević-Perić; B Jelaković; J H Lombard; M P Kunert; A Kibel; M Gros
Journal:  Kidney Blood Press Res       Date:  2010-11-12       Impact factor: 2.687

Review 3.  Dietary intake measurements.

Authors:  Ingrid H E Rutishauser
Journal:  Public Health Nutr       Date:  2005-10       Impact factor: 4.022

4.  Effect of High-Salt Diet on Age-Related High Blood Pressure and Hypothalamic Redox Signaling.

Authors:  Bilgen Basgut; Melissa A Whidden; Nataliya Kirichenko; Mary Woods; Benedek Erdos; Philip J Scarpace; Nihal Tümer
Journal:  Pharmacology       Date:  2017-05-19       Impact factor: 2.547

Review 5.  ACE polymorphisms.

Authors:  F A Sayed-Tabatabaei; B A Oostra; A Isaacs; C M van Duijn; J C M Witteman
Journal:  Circ Res       Date:  2006-05-12       Impact factor: 17.367

6.  Angiotensin-converting enzyme gene polymorphisms, blood pressure and pulse pressure in subjects with essential hypertension in a South Sulawesi Indonesian population.

Authors:  Haerani Rasyid; Syakib Bakri; Irawan Yusuf
Journal:  Acta Med Indones       Date:  2012-10

7.  Sodium Intake, Blood Pressure, and Dietary Sources of Sodium in an Adult South Indian Population.

Authors:  Sripriya Ravi; Odilia I Bermudez; Vijayakumar Harivanzan; Kwan Ho Kenneth Chui; Preethi Vasudevan; Aviva Must; Sadagopan Thanikachalam; Mohan Thanikachalam
Journal:  Ann Glob Health       Date:  2016 Mar-Apr       Impact factor: 2.462

8.  Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.

Authors:  Heriberto Rodríguez-Hernández; Luis E Simental-Mendía; Gabriela Rodríguez-Ramírez; Miguel A Reyes-Romero
Journal:  Int J Endocrinol       Date:  2013-04-17       Impact factor: 3.257

9.  Associations of ACE gene insertion/deletion polymorphism, ACE activity, and ACE mRNA expression with hypertension in a Chinese population.

Authors:  Qingfang He; Chunhong Fan; Min Yu; Gina Wallar; Zuo-Feng Zhang; Lixin Wang; Xinwei Zhang; Ruying Hu
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

10.  Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population.

Authors:  Ramalingam Krishnan; Durairaj Sekar; Santha Karunanithy; Sethupathy Subramanium
Journal:  Genes Dis       Date:  2016-03-25
View more
  3 in total

1.  Daily sodium intake influences the relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and hypertension in older adults.

Authors:  Ivna V Freire; Cezar A Casotti; Ícaro J S Ribeiro; Jonas R D Silva; Ana A L Barbosa; Rafael Pereira
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-09       Impact factor: 3.738

2.  Practical applicability of genetics for the prevention and treatment of hypertension.

Authors:  Alexandre Sérgio Silva
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-28       Impact factor: 3.738

3.  Analysis of Dose-response Relationship between BMI and Hypertension in Northeastern China Using Restricted Cubic Spline Functions.

Authors:  Yangming Qu; HuiKun Niu; Lu Li; Meiqi Li; Shoumeng Yan; Meng Li; Shan Jiang; Xiaoyu Ma; Bo Li; Hui Wu
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.